瑟利贝尔
CBLL
25.04
-2.60
-9.41%
瑟利贝尔
US · CBLL
#3313 按市值排名
上市于 2024
25.04
-2.60
-9.41%
实时 - 追踪5344个代码 - 心跳于137秒前
· 2026-10-16 19:39
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量增加了1家。
- 机构持股总比例下降了0.3个百分点。
机构持股
- 机构持股比例
- 95.62% -0.32pp
- 机构数量
- 167 +1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund48.00%
VC/PE Fund23.61%
Hedge Fund9.50%
Private Company7.62%
Individual/Insider5.50%
Family Office/Trust4.10%
Public Company2.59%
Insurance Company0.14%
主要股东 截至 2026-06-30
FMR
14.83% · 5.69M 股
TPG Capital, L.P.
9.80% · 3.76M 股
Longitude Capital Management Co., LLC
6.45% · 2.48M 股
Red Tree Venture Capital
5.75% · 2.21M 股
BlackRock
5.04% · 1.94M 股
The Global Value Investment Portfolio Management Pte Ltd.
4.10% · 1.57M 股
Vanguard Capital Management, LLC
3.38% · 1.30M 股
ACP Trust
3.33% · 1.28M 股
Kcm Capital, Inc.
2.93% · 1.13M 股
Xingjuan Chao
2.51% · 961.45K 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 10次买入 · 40次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Xingjuan Chao | Chief Executive Officer | 2.51% |
| Josef Parvizi | Director, Co-Founder & Chief Medical Advisor | 1.86% |
| Raymond Woo | Chief Technology Officer | 0.40% |
| Scott Blumberg | Chief Financial Officer | 0.25% |
| Joseph Manni | Officer | 0.15% |
| Joseph Taylor | Independent Director | 0.13% |
| David Foehr | Officer | 0.09% |
| Rebecca Robertson | Independent Chairperson | 0.07% |
| William Burke | Independent Director | 0.04% |
| Juliet Bakker | Independent Director | 0.02% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-30 | Raymond Woo | Chief Technology Officer | Derivative Exercise and Sale | -4,887 | $3.65–24.38 |
| 2026-09-14 | Scott Blumberg | Chief Financial Officer | Derivative Exercise and Sale | -846 | $9.41–25.00 |
| 2026-09-14 | Xingjuan Chao | Chief Executive Officer | Automatic Disposition | -20,846 | $25.03 |
| 2026-09-07 | Raymond Woo | Chief Technology Officer | Derivative Exercise and Sale | -4,887 | $3.65–24.33 |
| 2026-09-07 | Raymond Woo | Chief Technology Officer | Derivative Exercise and Retained | +8,389 | $2.24 |
| 2026-09-07 | David Foehr | Officer | Automatic Disposition | -1,755 | $24.26 |
| 2026-09-07 | David Foehr | Officer | Derivative Exercise and Sale | -7,500 | $4.70–24.25 |
| 2026-09-01 | Scott Blumberg | Chief Financial Officer | Derivative Exercise and Sale | -652 | $9.41–25.00 |
| 2026-09-01 | Xingjuan Chao | Chief Executive Officer | Automatic Disposition | -14,540 | $24.61 |
| 2026-09-01 | Xingjuan Chao | Chief Executive Officer | Derivative Exercise and Sale | -25,000 | $4.70–24.61 |
| 2026-08-23 | David Foehr | Officer | Automatic Disposition | -859 | $23.95 |
| 2026-08-20 | Scott Blumberg | Chief Financial Officer | Open Market Disposition | -1,521 | $24.02 |
| 2026-08-20 | Xingjuan Chao | Chief Executive Officer | Open Market Disposition | -6,068 | $24.02 |
| 2026-08-20 | Raymond Woo | Chief Technology Officer | Open Market Disposition | -1,979 | $24.02 |
| 2026-08-20 | Joseph Manni | Officer | Open Market Disposition | -1,361 | $24.02 |
| 2026-08-20 | David Foehr | Officer | Open Market Disposition | -993 | $24.02 |
| 2026-08-18 | Scott Blumberg | Chief Financial Officer | Derivative Exercise and Sale | -34,502 | $4.70–25.03 |
| 2026-08-18 | Scott Blumberg | Chief Financial Officer | Intent to Sell (Form 144) | -33,512 | $25.03 |
| 2026-08-18 | Xingjuan Chao | Chief Executive Officer | Automatic Disposition | -33,614 | $25.00–25.03 |
| 2026-08-18 | Xingjuan Chao | Chief Executive Officer | Intent to Sell (Form 144) | -31,415 | $25.03 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:39:41 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
瑟利贝尔 讨论区 0 条评论